Follow professional guidance: Only a licensed provider should determine your dosage and medication type
However, this decision should always be made in consultation with a healthcare provider and based on your complete cardiovascular risk profile, family history, and lipid levels
While the parent trials primary outcomes were changes in adipose tissue volume (measured by CT) and body composition (DXA scans) at 32 weeks, our current analysis focuses on epigenetic aging markers as secondary/exploratory outcomes
Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF
A better and more defensible statement is this: retatrutide may create a better body-composition opportunity, but actual muscle retention or gain still depends on training, protein, recovery, and treatment design
Understanding these layered mechanisms explains why semaglutide effects unfold over weeks rather than days